Assignee
HOTSPOT THERAPEUTICS INC
US·0 granted patents·11 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
11 records- 0161US2026085073A1Pyrazolylcarboxamide compounds and their use in therapyHOTSPOT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0260US2024150321A1Pyrazolylsulfonamide compounds and their use in therapyHOTSPOT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0360US2024150365A1Pyridinylsulfonamide compounds and their use in therapyHOTSPOT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0453US2025145622A1Solid forms of a triazine derivative as cbl-b modulatorHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0553US2024228482A1Compounds, compositions and methods of treating cancerHOTSPOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0647US2026085070A1Heterocyclic cbl-b inhibitors for the treatment of cancerHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0747US2025340552A1Compounds, compositions and methods of treating disordersHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0846US2025375428A1Cbl-b inhibitors and anti-pd1/anti-pd-l1 for use in the treatment of cancerHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0946US2025145623A1Methods of preparation of heterocyclic compoundsHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1045US2025161278A1Cbl-b inhibitor, compositions comprising a cbl-b inhibitor in a method of treating a disease associated with cell proliferationHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1145US2025152569A1Treatment of cell proliferation-associated conditions using a combination of a clb-b inhibitor and an additional therapeutic agentHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HOTSPOT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →